Naseem Zojwalla - Dec 16, 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Dec 16, 2024
Transactions value $
$68,180
Form type
4
Date filed
12/17/2024, 07:29 PM
Previous filing
Dec 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Options Exercise $68.2K +14K +12.12% $4.87 130K Dec 16, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -14K -11.04% $0.00 113K Dec 16, 2024 Common Stock 14K $4.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.